These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25357073)

  • 41. [Experimental and clinical results with the thrombin inhibitor Argatroban].
    Breddin HK
    Hamostaseologie; 2002 Aug; 22(3):55-9. PubMed ID: 12215762
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-dose argatroban for treatment of heparin-induced thrombocytopenia with thrombosis: a case report and review of laboratory considerations.
    Hellwig TR; Peitz GJ; Gulseth MP
    Am J Health Syst Pharm; 2012 Mar; 69(6):490-5. PubMed ID: 22382479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Direct thrombin inhibitors.
    Di Nisio M; Middeldorp S; Büller HR
    N Engl J Med; 2005 Sep; 353(10):1028-40. PubMed ID: 16148288
    [No Abstract]   [Full Text] [Related]  

  • 44. Influence of continuous veno-venous hemofiltration on argatroban clearance in a patient with septic shock.
    Schusterschitz N; Bellmann R; Stein M; Dunzendorfer S; Pechlaner C; Joannidis M
    Intensive Care Med; 2008 Jul; 34(7):1350-1. PubMed ID: 18297262
    [No Abstract]   [Full Text] [Related]  

  • 45. Argatroban: a synthetic thrombin inhibitor of low relative molecular mass.
    Fitzgerald D; Murphy N
    Coron Artery Dis; 1996 Jun; 7(6):455-8. PubMed ID: 8889361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical study of argatroban for preventing vascular thrombosis in the early period after pediatric living-related donor liver transplantation.
    Na L; Jindong H
    Pediatr Transplant; 2020 Mar; 24(2):e13654. PubMed ID: 31944491
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heparin-induced thrombocytopenia in haemodialysis treated with argatroban.
    Quiñones-Ortiz L; Suárez-Laurés A; Pablos-de Pablo M; Robles V; Calzón-Blanco C; Quiñones-Pérez S; Ayausty-Ruiz A
    Nefrologia; 2014; 34(5):670-4. PubMed ID: 25036261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of bivalirudin to lepirudin and argatroban in patients with heparin-induced thrombocytopenia.
    Bain J; Meyer A
    Am J Health Syst Pharm; 2015 Sep; 72(17 Suppl 2):S104-9. PubMed ID: 26272889
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ecarin Clotting Time: a predictive coagulation assay for the antithrombotic activity of argatroban in the rat.
    Berry CN; Lunven C; Girardot C; Lechaire I; Girard D; Charles MC; Ferrari P; O'Brien DP
    Thromb Haemost; 1998 Jan; 79(1):228-33. PubMed ID: 9459352
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial.
    Treschan TA; Schaefer MS; Geib J; Bahlmann A; Brezina T; Werner P; Golla E; Greinacher A; Pannen B; Kindgen-Milles D; Kienbaum P; Beiderlinden M
    Crit Care; 2014 Oct; 18(5):588. PubMed ID: 25344113
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aortic Arch Thrombus and Pulmonary Embolism in a COVID-19 Patient.
    Gandotra P; Supariwala A; Selim S; Garra G; Gruberg L
    J Emerg Med; 2021 Feb; 60(2):223-225. PubMed ID: 32917441
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Argatroban: pharmacological properties and anaesthesiological aspects].
    Kleinschmidt S; Stephan B; Pindur G; Bauer C
    Anaesthesist; 2006 Apr; 55(4):443-50. PubMed ID: 16389543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical application of the synthetic thrombin inhibitor, argatroban (MD-805).
    Matsuo T; Kario K; Kodama K; Okamoto S
    Semin Thromb Hemost; 1992; 18(2):155-60. PubMed ID: 1631564
    [No Abstract]   [Full Text] [Related]  

  • 54. Off-pump coronary artery bypass for a heparin-allergic patient.
    Ide H; Fujiki T; Sato M; Endo H; Imamura K; Sudo K
    Jpn J Thorac Cardiovasc Surg; 2001 Apr; 49(4):250-4. PubMed ID: 11355260
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.
    Lubenow N; Greinacher A
    J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():47-57. PubMed ID: 11155194
    [No Abstract]   [Full Text] [Related]  

  • 56. Idiopathic catastrophic thrombosis with happy ending.
    Heid J; Greinacher A; Katus HA; Müller OJ
    BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 29066639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Argatroban: a review of its use in the management of heparin-induced thrombocytopenia.
    Dhillon S
    Am J Cardiovasc Drugs; 2009; 9(4):261-82. PubMed ID: 19655821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Argatroban.
    Am J Health Syst Pharm; 2001 Nov; 58(21):2027-9. PubMed ID: 11715823
    [No Abstract]   [Full Text] [Related]  

  • 59. Argatroban in adult extracorporeal membrane oxygenation.
    Johnston N; Wait M; Huber L
    J Extra Corpor Technol; 2002 Dec; 34(4):281-4. PubMed ID: 12533066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study.
    Bath PM
    Stroke; 2012 Mar; 43(3):623-4. PubMed ID: 22223236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.